Has Sebastian Koch, MD received payments from drug or device companies?

Yes. Drug and device makers reported $959 in general payments to Sebastian Koch, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sebastian Koch, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sebastian Koch, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sebastian Koch, MD

Neurology · Miami, FLNPI 1831155779

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Genentech, Inc. at 37.8% of the total. Reporting peaked in 2019 at $426 and has fallen 92.7% since, to $31 in 2024. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.

$959in general payments, 2019–2025

Across 40 payments — averaging $23.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech, Inc.$363
Johnson & Johnson$150
E.r. Squibb & Sons, L.L.C.$137
Genentech USA, Inc.$125
Amgen$96
Microtransponder, Inc.$31
plus $56 from 3 others

$171,984in research payments, 2019–2025

Across 51 payments — averaging $3372.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$134K
Medtronic$38K

What the payments were for

Food & beverage$959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech, Inc.	4	$363
Johnson & Johnson	10	$150
E.r. Squibb & Sons, L.L.C.	8	$137
Genentech USA, Inc.	8	$125
Amgen	5	$96
Microtransponder, Inc.	1	$31
Supernus Pharmaceuticals, Inc.	2	$29
AstraZeneca	1	$15
Lilly USA, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TNKase$278

How this compares

$959 in reported general payments places this provider in the 40th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024

$63,445

Medicare patients

291

Services billed

487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	43	$27,588
Aimovig AutoinjectorErenumab-Aooe	20	$16,205
UbrelvyUbrogepant	16	$15,888
Clobazam	12	$4,171
Lacosamide	19	$2,942
Rivastigmine	15	$2,134
Memantine Hcl	44	$1,923
Levetiracetam	27	$1,688
Gabapentin	49	$909
Atorvastatin Calcium	76	$598
Amitriptyline Hcl	27	$582
Nifedipine ErNifedipine	12	$582
Donepezil Hcl	35	$542
Propranolol Hcl ErPropranolol Hcl	12	$433
Verapamil ErVerapamil Hcl	19	$416

Paid to pharmacies, not to this prescriber.

Other neurology in Miami

Diego Torres-RussottoMiami$652K
Bruno GalloMiami$313K
Brad HerskowitzMiami$273K
Flavia NelsonMiami$264K
Corneliu LucaMiami$257K
Kottil RammohanMiami$176K
Stuart IsaacsonBoca Raton$3.9M
Selim BenbadisTampa$2.1M
Derrick RobertsonTampa$1.8M
Robert HauserTampa$1.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →